ArticleNature communications2020

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.

Elodie Montaudon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.